General Archive

Home » Company updates » Page 2
  • News releases, Ventures funding

    LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

    LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has…

    Read more

  • Dave Powell headshot
    News releases

    LifeArc bolsters scientific leadership by appointing new Chief Scientific Officer

    Welcome to Dr Dave Powell, who has joined LifeArc as our first Chief Scientific Officer (CSO).  Dave is an experienced scientist and leader, with exceptional translational…

    Read more

  • Child holding adults hand
    News releases, Ventures funding

    LifeArc unveils new strategy and £1.3 billion spend to drive life-changing science

    Aims to transform the way diseases such as motor neurone disease are prevented, identified and treated.

    Read more

  • a gloved had holds a slide containing a purple sample in the foreground, a collection of purple vials in the background
    News releases

    MRCT and Chinese National Centre collaborate on malaria

    MRCT’s Drug Discovery Group has developed a drug screening assay for a potential Malaria drug target called PfSub-1, a subtilisin-like…

    Read more

  • A seedling in a mound of soil with two cupped hands gently touching the soil
    News releases

    MRC to receive over USD200m

    The Medical Research Council is to receive over US$200m as part of one of the biggest deals to come out…

    Read more